Delray Beach, Fla.-based DIABCO Healthware Software Solutions has appointed Virginia Greenwood as its new national sales manager. Greenwood brings 12 years of experience in sales and is also an expert in consulting and management services.

The word from Erika Williams, ombudsman for the National Supplier Clearinghouse, is that the final rule on provider standards could contain six to 10 more standards when it is issued. When will that be? No one knows, Williams said at last month's Medtrade.

WASHINGTON--The United States recovered more than $1.1 billion lost to fraud in federal health care programs for fiscal 2008, the Department of Justice said Nov. 10.

Cases involving whistleblowers accounted for a majority of the recoveries, according to a DOJ release. The figures bring total recoveries since 1986, when Congress substantially strengthened the False Claims Act, to more than $21 billion.

ATLANTA — Following CMS' Oct. 30 release of regulations involving changes to Medicare home oxygen policy and payment, some stakeholders involved in the sector said they believe the new rules are punitive.

While in July the Medicare Improvements for Patients and Providers Act reversed the oxygen equipment transfer to beneficiaries called for under 2005's Deficit Reduction Act, it left the DRA's 36-month oxygen rental cap in place.

ATLANTA — At an update on competitive bidding during Medtrade Oct. 28, Palmetto GBA Content and Policy Lead Cindy Dreher spoke to an audience of HME providers who slammed her with questions regarding changes to Round 1.2 and when it will happen. And though they left the session with Dreher's assurances of a "successful" process, they got no new information.

CHATSWORTH, Calif., and NAPLES, Fla. — CHAD Therapeutics announced Oct. 29 that that it has suspended operations due to the inability to raise additional capital. Following the sale of its oxygen business to Inovo in February, the company had been looking for capital to market products it was developing for the sleep disorder market, including its proprietary FloCHANNEL Diagnostic System, which received FDA clearance in July.